Current clinical practice guidelines for the treatment of renal cell carcinoma: A systematic review and critical evaluation Review uri icon

Overview

MeSH Major

  • Carcinoma, Renal Cell
  • Neoplasm Recurrence, Local
  • Vascular Endothelial Growth Factor A

abstract

  • Currently, there is uncertainity on the role of surgery in MRCC and on the choice of available guidelines in relapsed RCC. The best practice is individualization of targeted therapies. Systematic review of guidelines can help to identify unmet medical needs and areas of future research.

publication date

  • June 2017

Research

keywords

  • Review

Identity

Language

  • eng

PubMed Central ID

  • PMC5469586

Digital Object Identifier (DOI)

  • 10.1634/theoncologist.2016-0435

PubMed ID

  • 28592625

Additional Document Info

start page

  • 667

end page

  • 679

volume

  • 22

number

  • 6